{
    "2021-10-27": [
        [
            {
                "time": "",
                "original_text": "甘李药业：第三季度净利4.99亿元 同比增长32%",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "第三季度",
                        "净利",
                        "同比增长",
                        "32%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH)：第三季度净利增31.72%至4.99亿元",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "603087.SH",
                        "第三季度",
                        "净利",
                        "增长",
                        "31.72%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "图解甘李药业三季报：第三季度单季净利润同比增长31.72%",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "三季报",
                        "第三季度",
                        "单季",
                        "净利润",
                        "同比增长",
                        "31.72%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：2021年第三季度净利润约4.99亿元，同比增长31.72%",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "2021年",
                        "第三季度",
                        "净利润",
                        "同比增长",
                        "31.72%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：前三季度净利润同比增长26.99%",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "前三季度",
                        "净利润",
                        "同比增长",
                        "26.99%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股多数低迷，健帆生物、甘李药业、君实生物大跌并创阶段新低",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "低迷",
                        "健帆生物",
                        "甘李药业",
                        "君实生物",
                        "大跌",
                        "阶段新低"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}